Pharma News, 2019

AbbVie already has high hopes for newly approved immunology drug Skyrizi as its old megablockbuster Humira starts to fall.

SAN FRANCISCO—Sanofi’s Toujeo has been battling it out against Novo Nordisk’s Tresiba in the next-generation basal insulin market, but new data could give it an edge in one key pool of diabetes ...

For the second time in eight weeks, there have been deaths tied to an explosion at a pharmaceutical manufacturing facility, this time in India.

When Insys Therapeutics settled with the feds for a whopping $225 million last week on federal kickback charges, the drugmaker hoped it had put its troubled past behind it.

California is well-known for its position in the biotech and pharma industry, with two world-class hubs in the Bay Area and the San Diego region.

Kenilworth, NJ-based Merck & Co.

MEXICO CITY, June 7 (Xinhua) -- Mexican scientists created a skin patch targeting diabetic foot infections caused by antibiotic-resistant germs, National Polytechnic Institute (IPN) of...

(Reuters Health) - In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to resul...

BOTHELL, Wash.

THOUSAND OAKS, Calif.

PARIS - June 7, 2019 - At its meeting on June 6th of 2019, Sanofi's Board of Directors unanimously appointed Paul Hudson as Chief Executive Officer of the Group, to succeed Olivier Brandicourt w...

NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq.